Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells

被引:0
作者
Xiao, HY
Hasegawa, T
Isobe, K
机构
[1] Natl Inst Longev Sci, Dept Basic Gerontol, Aichi 4748522, Japan
[2] W China Univ Med Sci, Inst Canc Res, Chengdu 610041, Sichuan, Peoples R China
关键词
Sp1; Sp3; p21(WAF1); promoter; histone acetylation;
D O I
10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.3.CO;2-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylase inhibitor-induced expression of p21(WAF1) is p53 independent. In the present study, we provide evidence that trichostatin A (TSA), a specific inhibitor of histone deacetylase, can elevate H3 and H4 acetylation and p21(WAF1) expression in NIH3T3 cells at first. To identify the transcription factor which is responsible for histone deacetylase inhibitor-induced expression of p21(WAF1) and understand the potential events occurred during this process, we analyze the response of the mouse p21(WAF1) promoter to TSA in detail. The region responsive to TSA treatment in the p21 promoter is located -100 bp upstream from transcription initiation site and contains a GC-box. The mutation introduced into this GC-box decreases most of the basal and TSA-induced promoter activity. The results from gel-shift assay show that Sp1 and Sp3 bind to this GC-rich region. Cotransfection with Sp1 and/or Sp3 expression constructs elevate both basal and induced promoter activity, and this elevation is dependent on the present of the GC-box. By contrast, cotransfection with reverse oriented Sp1 or Sp3 cDNA decreased basal and induced-promoter activity as well as GC-box dependency. These findings provide physical and functional evidence which strongly indicated that both Sp1 and Sp3 are responsible for TSA-induced transactivation of the murine p21(WAF1) promoter in NIH3T3 cells. J. Cell. Biochem. 73:291-302, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 35 条
  • [1] Recruitment of p300/CBP in p53-dependent signal pathways
    Avantaggiati, ML
    Ogryzko, V
    Gardner, K
    Giordano, A
    Levine, AS
    Kelly, K
    [J]. CELL, 1997, 89 (07) : 1175 - 1184
  • [2] The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells
    Biggs, JR
    Kudlow, JE
    Kraft, AS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) : 901 - 906
  • [3] FUNCTIONAL-ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA RESPONSIVE ELEMENTS IN THE WAF1/CIP1/P21 PROMOTER
    DATTO, MB
    YU, Y
    WANG, XF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) : 28623 - 28628
  • [4] An inhibitor domain in Sp3 regulates its glutamine-rich activation domains
    Dennig, J
    Beato, M
    Suske, G
    [J]. EMBO JOURNAL, 1996, 15 (20) : 5659 - 5667
  • [5] P53-DEPENDENT INHIBITION OF CYCLIN-DEPENDENT KINASE-ACTIVITIES IN HUMAN FIBROBLASTS DURING RADIATION-INDUCED G1 ARREST
    DULIC, V
    KAUFMANN, WK
    WILSON, SJ
    TLSTY, TD
    LEES, E
    HARPER, JW
    ELLEDGE, SJ
    REED, SI
    [J]. CELL, 1994, 76 (06) : 1013 - 1023
  • [6] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [7] MODULATION OF CHROMATIN FOLDING BY HISTONE ACETYLATION
    GARCIARAMIREZ, M
    ROCCHINI, C
    AUSIO, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) : 17923 - 17928
  • [8] Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
    Gu, W
    Roeder, RG
    [J]. CELL, 1997, 90 (04) : 595 - 606
  • [9] INHIBITION OF CDK2 ACTIVITY IN-VIVO BY AN ASSOCIATED 20K REGULATORY SUBUNIT
    GU, Y
    TURCK, CW
    MORGAN, DO
    [J]. NATURE, 1993, 366 (6456) : 707 - 710
  • [10] CLONING BY RECOGNITION SITE SCREENING OF 2 NOVEL GT BOX BINDING-PROTEINS - A FAMILY OF SP1 RELATED GENES
    HAGEN, G
    MULLER, S
    BEATO, M
    SUSKE, G
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (21) : 5519 - 5525